Christoph Bruening insider trades: Callisto Pharmaceuticals (CLSP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christoph reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 19, 2010 | CLSP | ↓ Sell | 100,000 | $0.23 | $23K | Direct | Jan 20, 2010 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Christoph Bruening's insider trades
Christoph Bruening is a director at Callisto Pharmaceuticals (CLSP). Since Jan 19, 2010, Christoph has reported no open-market purchases and 1 sale worth $23K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLSP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.